We are live on ! Find out more
AMAG

AMAG Pharmaceuticals
AMAG

Delisted

AMAG was delisted on the 13th of November, 2020.

Back to rankings

187 hedge funds and large institutions have $774M invested in AMAG Pharmaceuticals in 2017 Q3 according to their latest regulatory filings, with 35 funds opening new positions, 68 increasing their positions, 54 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

75% more first-time investments, than exits

New positions opened: 35 | Existing positions closed: 20

26% more repeat investments, than reductions

Existing positions increased: 68 | Existing positions reduced: 54

7% more funds holding

Funds holding: 174 → 187 (+13)

3% less capital invested

Capital invested by funds: $802M → $774M (-$28M)

76% less call options, than puts

Call options by funds: $3.87M | Put options by funds: $16.4M

Holders
187
Holders Change
+13
Holders Change %
+7.47%
% of All Funds
4.66%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
35
Increased
68
Reduced
54
Closed
20
Calls
$3.87M
Puts
$16.4M
Net Calls
-$12.5M
Net Calls Change
-$3.13M

Top Buyers

Rank Fund Capital Flow
1
CCM
Camber Capital Management
Massachusetts
+$17.7M
2
PP
PDT Partners
New York
+$5.47M
3
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$4.45M
4
TAM
Tocqueville Asset Management
New York
+$4M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$3.99M

Top Sellers

Rank Fund Capital Flow
1
Invesco
Invesco
Georgia
-$25.5M
2
Citadel Advisors
Citadel Advisors
Florida
-$21.7M
3
GAM
Gotham Asset Management
New York
-$6.87M
4
State Street
State Street
Massachusetts
-$6.1M
5
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$6.07M
Name Holding Trade Value Shares
Change 		Change in
Stake
OAM
51
Oxford Asset Management
United Kingdom
$1.87M -$763K -40,947 -29%
MWNA
52
Marshall Wace North America
New York
$1.62M +$1.68M +90,085 New
SFM
53
Systematic Financial Management
New Jersey
$1.56M -$144K -7,715 -8%
California Public Employees Retirement System
54
California Public Employees Retirement System
California
$1.55M +$26.9K +1,441 +2%
BNP Paribas Financial Markets
55
BNP Paribas Financial Markets
France
$1.5M +$115K +6,147 +8%
Schroder Investment Management Group
56
Schroder Investment Management Group
United Kingdom
$1.49M +$787K +42,233 +101%
SM
57
Sabby Management
Florida
$1.48M -$163K -8,770 -10%
Citigroup
58
Citigroup
New York
$1.48M -$1.13M -60,512 -43%
BCM
59
Bridgeway Capital Management
Texas
$1.39M – – –
RhumbLine Advisers
60
RhumbLine Advisers
Massachusetts
$1.38M +$28.5K +1,530 +2%
Bank of America
61
Bank of America
North Carolina
$1.3M +$169K +9,094 +15%
BGIM
62
Brandywine Global Investment Management
Pennsylvania
$1.3M +$1.31M +70,250 New
HP
63
Hikari Power
Japan
$1.29M – – –
Massachusetts Financial Services
64
Massachusetts Financial Services
Massachusetts
$1.27M -$19.2K -1,030 -1%
Legal & General Group
65
Legal & General Group
United Kingdom
$1.26M +$14K +749 +1%
AIMCA
66
Alberta Investment Management Corp (AIMCo)
Alberta, Canada
$1.25M +$654K +35,100 +108%
Credit Agricole
67
Credit Agricole
France
$1.24M – – –
State of New Jersey Common Pension Fund D
68
State of New Jersey Common Pension Fund D
New Jersey
$1.22M – – –
TA
69
Teachers Advisors
New York
$1.19M +$39.1K +2,098 +3%
VRS
70
Virginia Retirement Systems
Virginia
$1.18M -$268K -14,400 -18%
VOYA Investment Management
71
VOYA Investment Management
Georgia
$1.14M -$592K -31,742 -34%
HCMT
72
Highland Capital Management (Texas)
Texas
$1.14M +$1.15M +61,500 New
AllianceBernstein
73
AllianceBernstein
Tennessee
$1.11M – – –
California State Teachers Retirement System (CalSTRS)
74
California State Teachers Retirement System (CalSTRS)
California
$1.04M -$105K -5,630 -9%
Swiss National Bank
75
Swiss National Bank
Switzerland
$1.04M – – –
1 2
3
4 5

AMAG Hedge Fund Activity: Q3 2017 in Review

187 of the 4,012 institutional investors tracked by Wall St. Rank reported a position in AMAG Pharmaceuticals (AMAG) for Q3 2017, worth a combined $774M — down 3.5% from $802M a quarter earlier.

Buyers outnumbered sellers: 35 funds opened new AMAG positions and 20 closed out — a net gain of 15 holders — while 68 added to existing stakes and 54 trimmed.

The largest buyer was Camber Capital Management, adding an estimated $17.7M. The largest seller was Invesco, cutting an estimated $25.5M.

  • 187 institutional investors held AMAG Pharmaceuticals (AMAG) as of Q3 2017, up from 174 in Q2 2017.
  • Funds reported $774M of AMAG Pharmaceuticals stock for Q3 2017, down 3.5% quarter-over-quarter.
  • 35 funds opened new AMAG Pharmaceuticals positions in Q3 2017 and 20 closed out, a net change of +15 holders.
  • The largest AMAG Pharmaceuticals buyer in Q3 2017 was Camber Capital Management, an estimated $17.7M added.
  • The largest AMAG Pharmaceuticals seller in Q3 2017 was Invesco, an estimated $25.5M sold.

Based on aggregated 13F filings for Q3 2017.